| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A boy with xeroderma pigmentosum and multiple types of skin cancer
|
Sarbay, H.
|
|
2019
|
85 |
S1 |
p. S73
|
artikel
|
| 2 |
A case of thrombotic thrombocytopenic purpura related to brucellosis
|
Balta, S.
|
|
2019
|
85 |
S1 |
p. S66
|
artikel
|
| 3 |
A case report of carfilzomib-induced hepatotoxicity
|
Menguc, M. Ulukoylu
|
|
2019
|
85 |
S1 |
p. S44
|
artikel
|
| 4 |
A case with a late recurring limited stage small cell lung cancer
|
Karaalioglu, B.
|
|
2019
|
85 |
S1 |
p. S75
|
artikel
|
| 5 |
A clinical analysis of 15 cases of coexistence of T-cell and B-cell lymphoma: a retrospective study of the Polish Lymphoma Research Group
|
Bartyzel, S.
|
|
2019
|
85 |
S1 |
p. S66
|
artikel
|
| 6 |
Acute liver failure secondary to dacarbazine use in a Hodgkin lymphoma patient
|
Cetıntepe, T.
|
|
2019
|
85 |
S1 |
p. S67
|
artikel
|
| 7 |
A descriptive study of multiple myeloma in Algerian population
|
Ibtissem, O.
|
|
2019
|
85 |
S1 |
p. S42
|
artikel
|
| 8 |
Adult-onset ligneous gingivitis associated with plasma cell dyscrasia in the absence of plasminogen deficiency
|
Aksoy, E.
|
|
2019
|
85 |
S1 |
p. S50
|
artikel
|
| 9 |
Analysis of the progression-free survival of CLL patients who received first-line bendamustine-rituximab therapy depending on the elimination rate of the minimum residual disease and mutational status IGHV genes
|
Miroliubova, I.
|
|
2019
|
85 |
S1 |
p. S26
|
artikel
|
| 10 |
A rare association, myelofibrosis secondary to essential thrombocytosis and monoclonal gammopathy of undetermined significance
|
Aras, M. Reis
|
|
2019
|
85 |
S1 |
p. S46
|
artikel
|
| 11 |
A rare case of gastric metastastasis from lung cancer
|
Teker, F.
|
|
2019
|
85 |
S1 |
p. S84
|
artikel
|
| 12 |
A rare cause of hemophagocytic lymphohistiocytosis Q fever: a case report
|
Sağlam, B.
|
|
2019
|
85 |
S1 |
p. S68
|
artikel
|
| 13 |
A rare complication of hematopoietic stem cell transplantation: Kaposi sarcoma
|
Bekoz, H.
|
|
2019
|
85 |
S1 |
p. S53
|
artikel
|
| 14 |
A regional hemovigilance study of transfusion-related adverse events at a university hospital from Istanbul
|
Kaftancıoğlu, Ü.
|
|
2019
|
85 |
S1 |
p. S61
|
artikel
|
| 15 |
A relapsed refractory CD30 positive cutaneous anaplastic large cell lymphoma with large B-cell transformation responding to brentuximab vedotin after multiple lines of treatment
|
Erdem, S.
|
|
2019
|
85 |
S1 |
p. S60
|
artikel
|
| 16 |
A relapsed/refractory multiple myeloma patient with central nervous system involvement
|
Cifttciler, R.
|
|
2019
|
85 |
S1 |
p. S43
|
artikel
|
| 17 |
Are maintenance post-transplant therapies needed?
|
Halahleh, Khalid
|
|
2019
|
85 |
S1 |
p. S13
|
artikel
|
| 18 |
A retrospective analysis of peripheral T-cell lymphoma patients: single-center ‘real-life’ experience
|
Ozbalak, M.
|
|
2019
|
85 |
S1 |
p. S32-S33
|
artikel
|
| 19 |
A room of my own
|
Ari-De Vries, L. Gov
|
|
2019
|
85 |
S1 |
p. S70
|
artikel
|
| 20 |
Asbestos-related malign mesothelioma: a single-center experience
|
Simsek, M.
|
|
2019
|
85 |
S1 |
p. S73
|
artikel
|
| 21 |
Association of human leukocyte antigen groups with oral mucositis in patients undergoing bone marrow transplantation
|
Tufan, A.
|
|
2019
|
85 |
S1 |
p. S52
|
artikel
|
| 22 |
Author index
|
|
|
2019
|
85 |
S1 |
p. S85-S88
|
artikel
|
| 23 |
Autoantibodies associated with major thalassemia
|
Amına, A.
|
|
2019
|
85 |
S1 |
p. S81
|
artikel
|
| 24 |
Autoimmunity associated with hepatitis C virus
|
Amına, A.
|
|
2019
|
85 |
S1 |
p. S51
|
artikel
|
| 25 |
Aza maintenance after consolidation increase RFS in MRDve+ low and not in intermediate risk AML patients
|
Girshova, L.
|
|
2019
|
85 |
S1 |
p. S31
|
artikel
|
| 26 |
Bad disease with reasonable outcomes: case report metastatic breast cancer with bone marrow and leptomeningeal disease
|
Osmani, A.
|
|
2019
|
85 |
S1 |
p. S71-S72
|
artikel
|
| 27 |
Behavior and outcomes of pregnancy associated breast cancer: a cohort study
|
Osmani, A.
|
|
2019
|
85 |
S1 |
p. S71
|
artikel
|
| 28 |
Behçet’s disease and T-cell large granular lymphocytic leukemia: two case reports
|
Tazegul, G.
|
|
2019
|
85 |
S1 |
p. S59-S60
|
artikel
|
| 29 |
Blastic plasmacytoid dendritic cell neoplasm: a rare case report
|
Güner, Ş. İzmir
|
|
2019
|
85 |
S1 |
p. S42
|
artikel
|
| 30 |
Breast cancer distribution in northwest Iran (East Azerbaijan province): results of a population-based cancer registry
|
Pashaie, S.
|
|
2019
|
85 |
S1 |
p. S75
|
artikel
|
| 31 |
Cancer stem cells (CSCs)
|
Chulkova, Svetlana V.
|
|
2019
|
85 |
S1 |
p. S25
|
artikel
|
| 32 |
Cardiac amyloidosis
|
Shabanova, S.
|
|
2019
|
85 |
S1 |
p. S63
|
artikel
|
| 33 |
CAR-T cell therapy in pediatrics
|
Schlegel, Patrick
|
|
2019
|
85 |
S1 |
p. S16
|
artikel
|
| 34 |
CAR T therapy for solid tumors
|
Adusumilli, Prasad
|
|
2019
|
85 |
S1 |
p. S14
|
artikel
|
| 35 |
Case of atrial fibrillation secondary to ibrutinib and resulting in death
|
Aras, M. Reis
|
|
2019
|
85 |
S1 |
p. S45-S46
|
artikel
|
| 36 |
CD34+ selected stem cell boost for CMV induced poor graft function after allogeneic stem cell transplantation
|
Abdullayev, E.
|
|
2019
|
85 |
S1 |
p. S45
|
artikel
|
| 37 |
Characteristics and outcome of patients with hematological malignancy admitted to intensive care unit: a single-centre experience
|
Maqsood, S.
|
|
2019
|
85 |
S1 |
p. S33
|
artikel
|
| 38 |
Characterization of MAPK signaling pathway in newly diagnosed multiple myeloma
|
Sergeeva, A.
|
|
2019
|
85 |
S1 |
p. S22
|
artikel
|
| 39 |
Chemotherapy-induced rhabdomyolysis in chidren with leukemia: a case report
|
Vural, S.
|
|
2019
|
85 |
S1 |
p. S82
|
artikel
|
| 40 |
Chimerism after stem cell transplantation for thalassemia patients
|
Alieva, N.
|
|
2019
|
85 |
S1 |
p. S79-S80
|
artikel
|
| 41 |
Circulating tumor cells in patients with breast cancer I–III stages
|
Ponomarev, V.
|
|
2019
|
85 |
S1 |
p. S71
|
artikel
|
| 42 |
Clinical characteristics of relapsed ovarian cancer patients with striking response to the bevacizumab at first relapse
|
Kose, F.
|
|
2019
|
85 |
S1 |
p. S34
|
artikel
|
| 43 |
Clinical features and possible prognostic factors in patients with marginal zone lymphoma: retrospective analysis from two centers
|
Cömert, P.
|
|
2019
|
85 |
S1 |
p. S33
|
artikel
|
| 44 |
Clinical implications of the methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism on outcomes of allogeneic hematopoietic stem cell transplantation: systemic literature review
|
Saleh, M. Mohammed
|
|
2019
|
85 |
S1 |
p. S64
|
artikel
|
| 45 |
Clinical relevance of minor histocompatibility antigens
|
Oguz, F. Savran
|
|
2019
|
85 |
S1 |
p. S28-S29
|
artikel
|
| 46 |
Colchicine and serum CA72-4 elevation
|
Gürbüz, M.
|
|
2019
|
85 |
S1 |
p. S35
|
artikel
|
| 47 |
Colon cancer in diabetic patients: does risk affect diagnosis at an early stage?
|
Karaca, M.
|
|
2019
|
85 |
S1 |
p. S34
|
artikel
|
| 48 |
Combination therapy of pegylated interferon alpha 2a and ruxolitinib in myelofibrosis: a case report
|
Hindilerden, F.
|
|
2019
|
85 |
S1 |
p. S48
|
artikel
|
| 49 |
Committees
|
|
|
2019
|
85 |
S1 |
p. ix
|
artikel
|
| 50 |
Comparison of quality of life between early and advanced stage ovarian cancer patients
|
Yalcın, Y.
|
|
2019
|
85 |
S1 |
p. S38
|
artikel
|
| 51 |
Congenital factor XIII deficiency with the presence of inhibitor: a case report
|
Karaman, S.
|
|
2019
|
85 |
S1 |
p. S82-S83
|
artikel
|
| 52 |
Consideration of new agents for incorporation into treatment guidelines in AML
|
Burnett, Alan K.
|
|
2019
|
85 |
S1 |
p. S3
|
artikel
|
| 53 |
Consolidation treatment with high-dose chemotherapy and radiotherapy in children and young adults with relapsed and refractory Hodgkin’s disease
|
Subbotina, N.
|
|
2019
|
85 |
S1 |
p. S80
|
artikel
|
| 54 |
Correlation of PET-CT with bone marrow biopsy to evaluate bone marrow infiltration in HL case series
|
Yetişir, A.
|
|
2019
|
85 |
S1 |
p. S56
|
artikel
|
| 55 |
Current treatment of acute promyelocytic leukemia
|
Sanz, Miguel A.
|
|
2019
|
85 |
S1 |
p. S1
|
artikel
|
| 56 |
CYP3A5*3, CYP3A4*18 and CYP2B6 gene polymorphisms in chronic myeloid leukemia patients in Azerbaijan
|
Asadov, C.
|
|
2019
|
85 |
S1 |
p. S30
|
artikel
|
| 57 |
Determination of the best cut-off metaphase percentage for discrimination of aging- versus myelodysplasia-related loss of Y chromosome
|
Aladag, E.
|
|
2019
|
85 |
S1 |
p. S41
|
artikel
|
| 58 |
Diagnosis of transcobalamin deficiency in a patient with pancytopenia: a case report
|
Yalvaç, Y.
|
|
2019
|
85 |
S1 |
p. S69
|
artikel
|
| 59 |
Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: a single-center experience
|
Frikha, R.
|
|
2019
|
85 |
S1 |
p. S66
|
artikel
|
| 60 |
Efficacy of therapeutic plasma exchange in the treatment of multiple myeloma patients with hyperviscosity syndrome: a single-centre experience
|
Cvetkovıc, Z.
|
|
2019
|
85 |
S1 |
p. S36
|
artikel
|
| 61 |
Epidemiology and clinical characteristics of acute myeloid leukemia: a retrospective analysis in Annaba, Algeria
|
Grıfı, F.
|
|
2019
|
85 |
S1 |
p. S54
|
artikel
|
| 62 |
Epigenetic therapy in childhood acute myeloid leukemias
|
Popa, Alexandr
|
|
2019
|
85 |
S1 |
p. S18
|
artikel
|
| 63 |
Epigenetic therapy in childhood acute myeloid leukemias
|
Popa, A.
|
|
2019
|
85 |
S1 |
p. S49-S50
|
artikel
|
| 64 |
Evaluation of platelet functional assay and investigation of its importance in patients
|
Esmaeli, N. Shagerdi
|
|
2019
|
85 |
S1 |
p. S37
|
artikel
|
| 65 |
Evaluation of secondary hypogammaglobulinemia in patients with hematologic malignancy receiving ibrutinib therapy
|
Çelik, S.
|
|
2019
|
85 |
S1 |
p. S39
|
artikel
|
| 66 |
Evaluation of the diagnostic power of the use of pediatric bleeding score in children with epistaxis
|
Alpcan, A.
|
|
2019
|
85 |
S1 |
p. S83
|
artikel
|
| 67 |
Evaluation of the prevalence of hepatitis B and C in patients with lymphoma
|
Togun, M.
|
|
2019
|
85 |
S1 |
p. S46
|
artikel
|
| 68 |
Evolving approaches in systemic therapy for triple-negative breast cancer in neoadjuvant and adjuvant settings
|
Er, Özlem
|
|
2019
|
85 |
S1 |
p. S15
|
artikel
|
| 69 |
Exercise program improves quality of life of the patients during the first 100 days following hematopoietic stem cell transplantation
|
Kabak, V. Yıldız
|
|
2019
|
85 |
S1 |
p. S69
|
artikel
|
| 70 |
Experience of thalassemia center
|
Huseynov, Valeh
|
|
2019
|
85 |
S1 |
p. S5
|
artikel
|
| 71 |
Extended half-life product (rFVIIIFC) for treatment of children with hemophilia A: preliminary post-switch experience from a tertiary care center
|
Alsaleh, M.
|
|
2019
|
85 |
S1 |
p. S81
|
artikel
|
| 72 |
Extranodal marginal zone lymphoma with orbital involvement: a case report
|
Tekinalp, A.
|
|
2019
|
85 |
S1 |
p. S67-S68
|
artikel
|
| 73 |
Feasibility of the Arabic version of distress thermometer for Egyptian patients with solid cancers and hematological malignancies
|
El-Azız, N. Abd
|
|
2019
|
85 |
S1 |
p. S29
|
artikel
|
| 74 |
Fertility preservation in pediatric oncology and hematopoietic stem cell transplantation
|
Erbey, Fatih
|
|
2019
|
85 |
S1 |
p. S20
|
artikel
|
| 75 |
Gastrointestinal plasmoblastic lymphoma associated with Wiskott-Aldrich syndrome: a case report
|
Ünal, A.
|
|
2019
|
85 |
S1 |
p. S45
|
artikel
|
| 76 |
Gemtuzumab ozogamicin in the treatment of critically ill patients with refractory acute myeloid leukemia
|
Zaytsev, D.
|
|
2019
|
85 |
S1 |
p. S65-S66
|
artikel
|
| 77 |
Gender differences: does it affect clinical characteristic and survival outcomes in adult acute lymphoblastic leukemia?
|
Cıftcıler, R.
|
|
2019
|
85 |
S1 |
p. S48-S49
|
artikel
|
| 78 |
Generic TKI: do they change the strategy of CML therapy?
|
Sacha, Tomasz
|
|
2019
|
85 |
S1 |
p. S4-S5
|
artikel
|
| 79 |
Genetic variations in tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) gene and the susceptibility to B cell non-Hodgkin lymphoma in Egypt
|
Khorshied, M.
|
|
2019
|
85 |
S1 |
p. S26-S27
|
artikel
|
| 80 |
HBA1C level correlation with iron deficiency anemia
|
Homafar, A.
|
|
2019
|
85 |
S1 |
p. S37
|
artikel
|
| 81 |
Health-related quality of life in children with acute lymphoblastic leukemia
|
Ocak, E.
|
|
2019
|
85 |
S1 |
p. S83-S84
|
artikel
|
| 82 |
Hematology Program
|
|
|
2019
|
85 |
S1 |
p. x-xvii
|
artikel
|
| 83 |
Hematology Specialist Association (HSA)
|
|
|
2019
|
85 |
S1 |
p. viii
|
artikel
|
| 84 |
Hemophagocytic lymphohistiocytosis: a case series of a Libyan institution
|
Malek, A.
|
|
2019
|
85 |
S1 |
p. S81-S82
|
artikel
|
| 85 |
Hemostasis changes in paroxysmal nocturnal hemoglobinuria
|
Toulon, Pierre
|
|
2019
|
85 |
S1 |
p. S3
|
artikel
|
| 86 |
How I treat multiple myeloma?
|
Maiolino, Angelo
|
|
2019
|
85 |
S1 |
p. S10-S11
|
artikel
|
| 87 |
How I treat relapsed/refractory DLBCL patients
|
De Souza, Carmino
|
|
2019
|
85 |
S1 |
p. S5-S6
|
artikel
|
| 88 |
HPV-associated head/neck cancer: new stagings and new treatments
|
Toraman, Kübra Özkaya
|
|
2019
|
85 |
S1 |
p. S14
|
artikel
|
| 89 |
Ibrutinib as a monotherapy for relapsed or refractory DLBCL patients: a single-center experience
|
Ekinci, O.
|
|
2019
|
85 |
S1 |
p. S55
|
artikel
|
| 90 |
Idiopathic pulmonary hemosiderosis: a rare cause of chronic anemia
|
Butt, A.
|
|
2019
|
85 |
S1 |
p. S54
|
artikel
|
| 91 |
Immune precision medicine in cancer
|
Rossi, Jean-François
|
|
2019
|
85 |
S1 |
p. S14
|
artikel
|
| 92 |
Impact of myeloproliferative neoplasms (MPNs) and perceptions of treatment goals amongst physicians and patients in 6 countries: an expansion of the MPN landmark survey
|
Saydam, G.
|
|
2019
|
85 |
S1 |
p. S60-S61
|
artikel
|
| 93 |
Importance of minimal disease detection in multiple myeloma
|
Terpos, Evangelos
|
|
2019
|
85 |
S1 |
p. S11-S12
|
artikel
|
| 94 |
Incidence of cytomegalovirus and Epstein–Barr infection after allogeneic bone marrow transplantation
|
Alakbarova, G.
|
|
2019
|
85 |
S1 |
p. S76-S77
|
artikel
|
| 95 |
Incidence of venous thromboembolism (VTE) in childhood cancers from a tertiary care centre: a unique registry initiative with an open invitation
|
Alsaleh, M.
|
|
2019
|
85 |
S1 |
p. S30-S31
|
artikel
|
| 96 |
Infected herpes zoster in a chronic lymphocytic leukemia patient treated with ibrutinib
|
Okay, M.
|
|
2019
|
85 |
S1 |
p. S40
|
artikel
|
| 97 |
Initial presentation of prostate cancer may hint different clinical characteristics along with serving predictive biomarker in castration-resistant prostate cancer patients treated with abiraterone acetate
|
Kose, F.
|
|
2019
|
85 |
S1 |
p. S34-S35
|
artikel
|
| 98 |
Isolated optic nerve and cerebral involvement without cerebrospinal fluid lymphoblastocytosis as a presenting sign of relapsed pediatric acute lymphoblastic leukemia
|
Karakurt, N.
|
|
2019
|
85 |
S1 |
p. S79
|
artikel
|
| 99 |
Is prescribing acid suppressive drugs for every patient is a good decision: a pH+ all case report
|
Günay, A.
|
|
2019
|
85 |
S1 |
p. S62
|
artikel
|
| 100 |
Is there any impact of uric acid levels during the peri-transplant period on acute graft vs. disease incidence and allotransplant outcome?
|
Kaloyannıdıs, P.
|
|
2019
|
85 |
S1 |
p. S21-S22
|
artikel
|
| 101 |
Lack of association between MTHFR C677T and risk of chronic myeloid leukemia
|
Jemaa, M. Ben
|
|
2019
|
85 |
S1 |
p. S67
|
artikel
|
| 102 |
Late renal aspergilloma after autologous stem cell transplantion mimicking secondary malignancy
|
Altınkaynak, M.
|
|
2019
|
85 |
S1 |
p. S64
|
artikel
|
| 103 |
Localized skin edema associated with ATRA in a patient with acute promyelocytic leukemia: a case report
|
Sağlam, B.
|
|
2019
|
85 |
S1 |
p. S56-S57
|
artikel
|
| 104 |
Long-time overlooked blastic plasmacytoid dendritic cell neoplasm evolving into multiple organ involvement presentation
|
Istemihan, Z.
|
|
2019
|
85 |
S1 |
p. S47
|
artikel
|
| 105 |
LYN and HDX gene mutations in patients with acute promyelocytic leukemia
|
Gheisari, E.
|
|
2019
|
85 |
S1 |
p. S48
|
artikel
|
| 106 |
Measurable residual diseases in haematological malignancies: current applications and future direction
|
Bakr, S.
|
|
2019
|
85 |
S1 |
p. S38
|
artikel
|
| 107 |
Metabolic syndrome post allogeneic stem cell transplantation in adult patients is not an uncommon complication: a single-center experience
|
Kaloyannıdıs, P.
|
|
2019
|
85 |
S1 |
p. S63-S64
|
artikel
|
| 108 |
Misleading metastatic cystic brain with raised inflammatory markers in undiagnosed NSCLC
|
Malek, A.
|
|
2019
|
85 |
S1 |
p. S73-S74
|
artikel
|
| 109 |
Modern approaches to diagnosis and treatment of various clinical forms of polycythemia vera
|
Khalilova, F.
|
|
2019
|
85 |
S1 |
p. S24
|
artikel
|
| 110 |
Modern approaches to diagnosis and treatment of various clinical forms of polycythemia vera
|
Khalilova, F.
|
|
2019
|
85 |
S1 |
p. S51-S52
|
artikel
|
| 111 |
Molecular markers in chronic lymphocytic leukemia (CLL)
|
Panayiotidis, P.
|
|
2019
|
85 |
S1 |
p. S7
|
artikel
|
| 112 |
Molecular monitorization of CML under TKI therapy
|
Saydam, Guray
|
|
2019
|
85 |
S1 |
p. S3-S4
|
artikel
|
| 113 |
Monitoring serum ferritin overload in beta-thalassemia intermedia and major patients in Azerbaijan
|
Aliyeva, D.
|
|
2019
|
85 |
S1 |
p. S77
|
artikel
|
| 114 |
Morbidity symptoms of myeloproliferative neoplasia
|
Altareb, M.
|
|
2019
|
85 |
S1 |
p. S51
|
artikel
|
| 115 |
MRD as an optimal treatment outcome assessment tool
|
Shervashidze, M.
|
|
2019
|
85 |
S1 |
p. S67
|
artikel
|
| 116 |
Muscle strength is associated with activities and participation level in children with acute lymphoblastic leukemia undergoing consolidation therapy
|
Kabak, V. Yıldız
|
|
2019
|
85 |
S1 |
p. S84
|
artikel
|
| 117 |
New drugs for CLL
|
Cuneo, Antonio
|
|
2019
|
85 |
S1 |
p. S7-S10
|
artikel
|
| 118 |
New hemostatic agents in bleeding and coagulation abnormalities
|
Cancelas, Jose A.
|
|
2019
|
85 |
S1 |
p. S5
|
artikel
|
| 119 |
Next-generation sequencing panel in de novo acute myeloid leukemia
|
Bolaman, A.
|
|
2019
|
85 |
S1 |
p. S69-S70
|
artikel
|
| 120 |
NG2 expressin in adults acute myeloid leukemia in Egypt
|
Gawaly, A.
|
|
2019
|
85 |
S1 |
p. S40
|
artikel
|
| 121 |
Non-malignant haematological disease (thalassemia, sickle cell) or multiple myeloma)
|
Aerts, Erik
|
|
2019
|
85 |
S1 |
p. S19-S20
|
artikel
|
| 122 |
Novel therapy for relapsed childhood acute lymphoblastic leukemia
|
Hazar, Volkan
|
|
2019
|
85 |
S1 |
p. S17-S18
|
artikel
|
| 123 |
Nursing Program
|
|
|
2019
|
85 |
S1 |
p. xviii
|
artikel
|
| 124 |
Oral chronic graft-versus-host disease
|
Treister, Nathaniel S.
|
|
2019
|
85 |
S1 |
p. S14
|
artikel
|
| 125 |
Oral Presentations
|
|
|
2019
|
85 |
S1 |
p. S21-S39
|
artikel
|
| 126 |
Orbital tumor board: life saver or time waster?
|
Butt, A.
|
|
2019
|
85 |
S1 |
p. S74-S75
|
artikel
|
| 127 |
Original versus generic lenalidomide in patients with relapsed multiple myeloma: comparison of effectivity and adverse events
|
Bolaman, A.
|
|
2019
|
85 |
S1 |
p. S23
|
artikel
|
| 128 |
Outcome of allogeneic stem cell transplant in adolescent and young patients with monosomy 7 in hematological malignancies
|
Ahmed, S.
|
|
2019
|
85 |
S1 |
p. S33-S34
|
artikel
|
| 129 |
Outcome of autologous stem cell transplantation in multiple myeloma, in the era of novel agents: a single-centre experience
|
Bafna, V.
|
|
2019
|
85 |
S1 |
p. S41
|
artikel
|
| 130 |
Outcomes of a newly formed multidisciplinary retinoblastoma service
|
Butt, A.
|
|
2019
|
85 |
S1 |
p. S74
|
artikel
|
| 131 |
Overcoming the resistance in HER2(+) metastatic breast cancer
|
Uzunoğlu, Sernaz
|
|
2019
|
85 |
S1 |
p. S15
|
artikel
|
| 132 |
Parvovirus B19 induced posterior reversible encephalopathy syndrome in a patient with relapse acute lymphoblastic leukemia
|
Sarbay, H.
|
|
2019
|
85 |
S1 |
p. S77-S78
|
artikel
|
| 133 |
Patients with thalassemia major receiving hemotransfusion: specifications of chelation therapy depending on ferritin level
|
Huseynov, V.
|
|
2019
|
85 |
S1 |
p. S78
|
artikel
|
| 134 |
Pediatric nasopharyngeal mass: a case report
|
Sarbay, H.
|
|
2019
|
85 |
S1 |
p. S72
|
artikel
|
| 135 |
Pegylated interferon alfa-2a is effective and decreases LDH levels in patients with essential thrombocythemia and polycythemia vera
|
Ekinci, O.
|
|
2019
|
85 |
S1 |
p. S27
|
artikel
|
| 136 |
POEMS syndrome treated with autologous hematopoietic stem cell transplantation
|
Abdullayev, E.
|
|
2019
|
85 |
S1 |
p. S44-S45
|
artikel
|
| 137 |
Poster Presentations: Adult Hematology
|
|
|
2019
|
85 |
S1 |
p. S40-S70
|
artikel
|
| 138 |
Poster Presentations: Oncology
|
|
|
2019
|
85 |
S1 |
p. S70-S76
|
artikel
|
| 139 |
Poster Presentations: Pediatric Hematology
|
|
|
2019
|
85 |
S1 |
p. S76-S84
|
artikel
|
| 140 |
Poster Presentations: Pediatric Hematology
|
|
|
2019
|
85 |
S1 |
p. S76
|
artikel
|
| 141 |
Precision medicine for CML
|
Saglio, Giuseppe
|
|
2019
|
85 |
S1 |
p. S1
|
artikel
|
| 142 |
Precision medicine in MDS
|
Cetiner, Mustafa
|
|
2019
|
85 |
S1 |
p. S1-S2
|
artikel
|
| 143 |
Prevalence of thalassemia syndromes, hemoglobinopathies and mutation analysis in a tribal school in India
|
Oberoi, A.
|
|
2019
|
85 |
S1 |
p. S77
|
artikel
|
| 144 |
Primary Ewing sarcoma of the kidney
|
Abdullayev, E.
|
|
2019
|
85 |
S1 |
p. S70-S71
|
artikel
|
| 145 |
Production of immortal squamous cell line from larynx carcinoma
|
Demirci, A.
|
|
2019
|
85 |
S1 |
p. S37-S38
|
artikel
|
| 146 |
Prognostic implication of Notch 1 expression among adult patients with normal cytogenetic acute myeloid leukaemia
|
Elyamany, G.
|
|
2019
|
85 |
S1 |
p. S26
|
artikel
|
| 147 |
Prognostic value of pretreatment systemic inflammation index in metastatic lung adenocarcinoma
|
Çınkır, H. Yeşil
|
|
2019
|
85 |
S1 |
p. S75-S76
|
artikel
|
| 148 |
Proptosis of eye: an unusual presentation of genitourinary malignancy: case report on prostate cancer
|
Saleem, Q.
|
|
2019
|
85 |
S1 |
p. S72
|
artikel
|
| 149 |
Quality of life and activity and participation of children with acute lymphoblastic leukemia are associated each other
|
Ipek, F.
|
|
2019
|
85 |
S1 |
p. S37
|
artikel
|
| 150 |
Recognizing genetic susceptibility in children with leukemia and lymphoma: the current state in European centers
|
Lazic, Jelena
|
|
2019
|
85 |
S1 |
p. S39
|
artikel
|
| 151 |
Recombination frequencies in HLA loci among Turkish patients with hematological malignancies and their family-based donors
|
Çınar, Ç. Kekik
|
|
2019
|
85 |
S1 |
p. S62-S63
|
artikel
|
| 152 |
Red blood cell alloantibodies in thalassemia major patients: an analysis from Istanbul
|
Yanaşık, M.
|
|
2019
|
85 |
S1 |
p. S62
|
artikel
|
| 153 |
Regulatory T cells in peripheral blood and bone marrow in patients with B-cell lymphoproliferative diseases
|
Mushkarına, T.
|
|
2019
|
85 |
S1 |
p. S21
|
artikel
|
| 154 |
Relation between fatigue and quality of life in cancer patients receiving outpatient chemotherapy
|
Ipek, F.
|
|
2019
|
85 |
S1 |
p. S22
|
artikel
|
| 155 |
Relationship between liver iron concentration determined by liver MRI (SIR method) serum ferritin and liver enzymes in patients with thalassemia major
|
Huseynov, V.
|
|
2019
|
85 |
S1 |
p. S79
|
artikel
|
| 156 |
Renal involvement in chronic lymphocytic leukemia: a case report
|
Demircioğlu, S.
|
|
2019
|
85 |
S1 |
p. S58
|
artikel
|
| 157 |
Results of escBEACOPP therapy in children with Hodgkin’s lymphoma (II+bulky, III, IV studies)
|
Belyaeva, E.
|
|
2019
|
85 |
S1 |
p. S53-S54
|
artikel
|
| 158 |
Richter transformation in patients with chronic lymphocytic leukemia: three cases and literature review
|
Cömert, P.
|
|
2019
|
85 |
S1 |
p. S57
|
artikel
|
| 159 |
Risk factors for invasive fungal infection in patients who underwent allogeneic hematopoietic stem cell transplantation
|
Yildizhan, E.
|
|
2019
|
85 |
S1 |
p. S60
|
artikel
|
| 160 |
Risk stratification and treatment of chronic lymphocytic leukemia (CLL)
|
Foà, Robin
|
|
2019
|
85 |
S1 |
p. S6-S7
|
artikel
|
| 161 |
Rituximab reduction for pediatric advanced-stage Burkitt lymphoma
|
Valiev, T.
|
|
2019
|
85 |
S1 |
p. S30
|
artikel
|
| 162 |
Role of CD117 in AML diagnostics in children
|
Palladına, A.
|
|
2019
|
85 |
S1 |
p. S76
|
artikel
|
| 163 |
Role of [68Ga]-pentixafor-PET/CT as a novel imaging of cxcr4 expression in multiple myeloma; comparison to [18F]-FDG-PET/CT
|
Tiryaki, T.
|
|
2019
|
85 |
S1 |
p. S24
|
artikel
|
| 164 |
Ruxolitinib for polycythemia vera and essential thrombocytosis: a single-center experience
|
Ekinci, O.
|
|
2019
|
85 |
S1 |
p. S55
|
artikel
|
| 165 |
Secondary AML patients with poor risk cytogenetics have a high risk of death post allogeneic stem cell transplantation in absence of chronic GVHD
|
Hassanein, M.
|
|
2019
|
85 |
S1 |
p. S22
|
artikel
|
| 166 |
Serological weak d phenotypes and RHD genotype frequency among Turkish blood donors
|
Yanaşık, M.
|
|
2019
|
85 |
S1 |
p. S53
|
artikel
|
| 167 |
SH2-containing tyrosine phosphatase-1 (SHP-1) MRNA expression and its promoter methylation in imatinib response in Egyptian chronic myeloid leukemia patients
|
Elkoney, N.
|
|
2019
|
85 |
S1 |
p. S32
|
artikel
|
| 168 |
Short-term survival outcomes and clinical characteristic of adult acute myeloid leukemia patients
|
Ciftciler, R.
|
|
2019
|
85 |
S1 |
p. S49
|
artikel
|
| 169 |
Single-center experience: comparison of reduced intensive chemotherapy and low-dose cytarabine treatment as remission induction in older age aml cases
|
Yikilmaz, A. Senturk
|
|
2019
|
85 |
S1 |
p. S41-S42
|
artikel
|
| 170 |
Single institution experience of thymoma and thymic carcinoma patients
|
Sımsek, M.
|
|
2019
|
85 |
S1 |
p. S25
|
artikel
|
| 171 |
Small round cell tumors
|
Erdoğan, Kıvılcım Eren
|
|
2019
|
85 |
S1 |
p. S15
|
artikel
|
| 172 |
Speaker Biographies
|
|
|
2019
|
85 |
S1 |
p. xix-xxxvi
|
artikel
|
| 173 |
Speaker Presentations
|
|
|
2019
|
85 |
S1 |
p. S1
|
artikel
|
| 174 |
Specifications of chelation therapy in patients with thalassemia intermedia and other thalassemia disorders
|
Jalilova, S.
|
|
2019
|
85 |
S1 |
p. S78
|
artikel
|
| 175 |
Spectrum and geographical distribution of beta-thalassemia mutations in Azerbaijan
|
Aliyeva, G.
|
|
2019
|
85 |
S1 |
p. S24-S25
|
artikel
|
| 176 |
Studying the problems of connected pathological condition of the liver in children with acute lymphoblastic leukemia
|
Babayev, M.
|
|
2019
|
85 |
S1 |
p. S59
|
artikel
|
| 177 |
Successful treatment of relapsed and refractory cold agglutinin disease with bortezomib: case report
|
Çelik, S.
|
|
2019
|
85 |
S1 |
p. S68-S69
|
artikel
|
| 178 |
Successful treatment of transplant-associated thrombotic microangiopathy with eculizumab
|
Demircioğlu, S.
|
|
2019
|
85 |
S1 |
p. S58
|
artikel
|
| 179 |
Successful treatment with azacytidine for simultaneous occurrence of acute myelomonocytic leukemia and multiple myeloma
|
Ataş, Ü.
|
|
2019
|
85 |
S1 |
p. S65
|
artikel
|
| 180 |
Suppression of miRNA-223 in adult acute myeloid leukemia is associated with adverse cytogenetic profile and undifferentiated blast morphology
|
Elyamany, G.
|
|
2019
|
85 |
S1 |
p. S47
|
artikel
|
| 181 |
Synchronous gastric malt lymphoma and adenocarcinoma with concurrent pulmonary malt lymphoma
|
Erkek, E. Turan
|
|
2019
|
85 |
S1 |
p. S31
|
artikel
|
| 182 |
T-cell Brazil project: preliminary results after 2 years of T-cell lymphoma registry
|
De Souza, C.
|
|
2019
|
85 |
S1 |
p. S31-S32
|
artikel
|
| 183 |
The approach and diagnosis of Coombs negative hemolytic anemias
|
Iolascon, Achille
|
|
2019
|
85 |
S1 |
p. S19
|
artikel
|
| 184 |
The association between hemogram parameters and survival in advanced stage diffuse large B cell lymphomas
|
Yasın, A.
|
|
2019
|
85 |
S1 |
p. S54-S55
|
artikel
|
| 185 |
The beneficial effects of varicella zoster virus
|
Al-Anazi, K.
|
|
2019
|
85 |
S1 |
p. S65
|
artikel
|
| 186 |
The course of acute leukemia in a patient with Down syndrome
|
Babayev, M.
|
|
2019
|
85 |
S1 |
p. S59
|
artikel
|
| 187 |
The current situation of multiple myeloma in Azerbaijan
|
Asadov, C.
|
|
2019
|
85 |
S1 |
p. S29
|
artikel
|
| 188 |
The effect of chemotherapy on survival applied in the last term of life in cancer patients
|
Isik, U.
|
|
2019
|
85 |
S1 |
p. S36
|
artikel
|
| 189 |
The efficacy and safety of granulocyte transfusion in pediatric neutropenic patients
|
Kagızmanlı, G. Akın
|
|
2019
|
85 |
S1 |
p. S23
|
artikel
|
| 190 |
The efficacy of postoperative radiotherapy in fibromatosis
|
Arslantaş, H.S.
|
|
2019
|
85 |
S1 |
p. S35-S36
|
artikel
|
| 191 |
The efficacy of reuse therapeutic plasma exchange in relapsed/refractory immune-mediated thrombotic thrombocytopenic purpura: a single-center experience of 130 cases
|
Mastanzade, M. Güzel
|
|
2019
|
85 |
S1 |
p. S52-S53
|
artikel
|
| 192 |
The epidemiological patterns and comparative assessment of treatment options in chronic myeloproliferative neoplasms
|
Musteata, V.
|
|
2019
|
85 |
S1 |
p. S50-S51
|
artikel
|
| 193 |
The impact of blinatumomab administration prior to allogeneic stem cell transplantation on the immune reconstitution post allografting
|
Kaloyannıdıs, P.
|
|
2019
|
85 |
S1 |
p. S61
|
artikel
|
| 194 |
The impact of iron deficiency on blood cell volume
|
Yorguc, M.
|
|
2019
|
85 |
S1 |
p. S63
|
artikel
|
| 195 |
The incidence and clinical impact of endocrine incidentalomas in hematologic malignancies: a single-center experience
|
Turgut, S.
|
|
2019
|
85 |
S1 |
p. S28
|
artikel
|
| 196 |
The incidence of venous thromboembolism in post-bariatric surgery patients
|
Alshuaıbı, T.
|
|
2019
|
85 |
S1 |
p. S58-S59
|
artikel
|
| 197 |
The investigation of plasma viscosity and endothelial dysfunction markers between patients diagnosed with essential thrombocytosis and reactive thrombocytosis
|
Karıs, D.
|
|
2019
|
85 |
S1 |
p. S50
|
artikel
|
| 198 |
The nurse and patient partnership in lymphomas
|
Aerts, Erik
|
|
2019
|
85 |
S1 |
p. S19
|
artikel
|
| 199 |
The patient who developed PRES after allogeneic stem cell transplantation
|
Eser, A.
|
|
2019
|
85 |
S1 |
p. S57
|
artikel
|
| 200 |
The predictive value of MRI and 18F-FDG-PET/CT for assessing pathological response in locally advanced rectal cancer after neoadjuvant chemoradiotherapy
|
Avcı, G. Guler
|
|
2019
|
85 |
S1 |
p. S35
|
artikel
|
| 201 |
The prophylaxis and the treatment of hepatic veno-occlusive disease after pediatric hematopoetic stem cell transplantation: our single-centre experience
|
Karagün, B.
|
|
2019
|
85 |
S1 |
p. S21
|
artikel
|
| 202 |
Therapeutic modulation of pleural effusion environment: the Next-Gen immunotherapy
|
Donnenberg, Vera S.
|
|
2019
|
85 |
S1 |
p. S12
|
artikel
|
| 203 |
The ratio of hemoglobin-to-red cell distribution width could predict survival in advanced pancreatic adenocarcinoma
|
Mirili, C.
|
|
2019
|
85 |
S1 |
p. S74
|
artikel
|
| 204 |
The results of treatment with the use of different generations of tyrokinases in patients with CML in the Kyrgyz Republic
|
Zhusupova, S.
|
|
2019
|
85 |
S1 |
p. S56
|
artikel
|
| 205 |
The role of ETS-1 transcription factor in the pathogenesis of chronic lymphocytic leukemia
|
Karakuş, V.
|
|
2019
|
85 |
S1 |
p. S47-S48
|
artikel
|
| 206 |
The role of hepatitis B-related chronic liver disease on the changes of iron parameters, B12 and folic acid levels
|
Cıftcıler, R.
|
|
2019
|
85 |
S1 |
p. S43-S44
|
artikel
|
| 207 |
The secretome of malignant pleural effusions: clues to targets of therapy
|
Donnenberg, Albert D.
|
|
2019
|
85 |
S1 |
p. S12-S13
|
artikel
|
| 208 |
The significance of geriatric assessment in elderly patients with B-cell non-Hodgkin lymphoma: a single-centre experience
|
Cvetkovıc, Z.
|
|
2019
|
85 |
S1 |
p. S28
|
artikel
|
| 209 |
The significant application of the 4T criteria in assessing the proper need for a HIT study assay in a Saudi tertiary care hospital
|
Elgohary, G.
|
|
2019
|
85 |
S1 |
p. S40-S41
|
artikel
|
| 210 |
The use of BMT with malignant lymphomas: practical issues based on St. Petersburg hematological center experience
|
Mikhailova, Natalia
|
|
2019
|
85 |
S1 |
p. S2
|
artikel
|
| 211 |
Thiotepa-based conditioning and autologous stem cell transplantation in children with high-risk medulloblastoma
|
Daylidite, V.
|
|
2019
|
85 |
S1 |
p. S23-S24
|
artikel
|
| 212 |
Thrombotic thrombocytopenic purpura associated with pesticides: a report of four cases and literature review
|
Karakuş, V.
|
|
2019
|
85 |
S1 |
p. S43
|
artikel
|
| 213 |
Title page
|
|
|
2019
|
85 |
S1 |
p. iii
|
artikel
|
| 214 |
Transfusion support of patients following HSCT
|
Cohn, Claudia S.
|
|
2019
|
85 |
S1 |
p. S5
|
artikel
|
| 215 |
Transplant activities, experience
|
Parmar, Lalith
|
|
2019
|
85 |
S1 |
p. S15-S16
|
artikel
|
| 216 |
Transplant activities, experience
|
Baassiri, Malek
|
|
2019
|
85 |
S1 |
p. S15
|
artikel
|
| 217 |
Treatment approach and results of therapy relapse/refractory patients with acute lymphoblastic leukemia in Talassemia Center Baku
|
Mammadova, G.
|
|
2019
|
85 |
S1 |
p. S80-S81
|
artikel
|
| 218 |
Treatment approach to thalassemia patients with alloimmunization at the Baku Thalassemia Center
|
Bagirova, K.
|
|
2019
|
85 |
S1 |
p. S80
|
artikel
|
| 219 |
Two different myeloproliferative neoplasms due to JAK2V617F mutation of two siblings
|
Turgutkaya, A.
|
|
2019
|
85 |
S1 |
p. S55-S56
|
artikel
|
| 220 |
Two-year experience of a multidisciplinary approach for pediatric thrombosis in a tertiary referral center
|
Karakas, Z.
|
|
2019
|
85 |
S1 |
p. S27
|
artikel
|
| 221 |
Unclassifiable non-CML classical myeloproliferative diseases with microcytosis: findings indicating diagnosis of polycythemia vera masked by iron deficiency
|
Aladag, E.
|
|
2019
|
85 |
S1 |
p. S41
|
artikel
|
| 222 |
Unrelated donorship in Russia: donors’ register (Kirov hematological institute)
|
Loginova, Maria
|
|
2019
|
85 |
S1 |
p. S2-S3
|
artikel
|
| 223 |
Update on collections for HPC and CAR-T
|
Padmanabhan, Anand
|
|
2019
|
85 |
S1 |
p. S10
|
artikel
|
| 224 |
Update on extracorporeal photopheresis (ECP)
|
Schneiderman, Jennifer
|
|
2019
|
85 |
S1 |
p. S10
|
artikel
|
| 225 |
Update on HLH treatment
|
Unal, Sule
|
|
2019
|
85 |
S1 |
p. S18-S19
|
artikel
|
| 226 |
Update on therapeutic apheresis indications
|
Schwartz, Joseph
|
|
2019
|
85 |
S1 |
p. S10
|
artikel
|
| 227 |
Upregulating hemoglobin F using CRISPR/Cas9 gene editing in beta-thalassemia and sickle cell disease
|
Chapin, John
|
|
2019
|
85 |
S1 |
p. S16
|
artikel
|
| 228 |
Wait and watch, or test for anti-granulocyte antibody
|
Coşkun, Ç.
|
|
2019
|
85 |
S1 |
p. S83
|
artikel
|
| 229 |
Welcome Address
|
|
|
2019
|
85 |
S1 |
p. vii
|
artikel
|
| 230 |
Will Car T-cell therapy replace hematopoietic stem cells transplant?
|
Saglio, Francesco
|
|
2019
|
85 |
S1 |
p. S13-S14
|
artikel
|
| 231 |
Xanthohumol induce apoptosis through p38 MAPK signaling pathway in human nasopharyngeal cancer cells
|
Lo, M.
|
|
2019
|
85 |
S1 |
p. S70
|
artikel
|
Tijdschrift beschrijving